About BioSymetrics
BioSymetrics is a company based in New York (United States) founded in 2015. BioSymetrics has raised $4.88 million across 1 funding round. BioSymetrics offers products and services including AI Discovery Platform. BioSymetrics operates in a competitive market with competitors including Causaly, Atomwise, ScienceIO, MicroHealth and Collaborative Drug Discovery, among others.
- Headquarter New York, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lunfarda Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.88 M (USD)
in 1 rounds
-
Latest Funding Round
$4.88 M (USD), Series A
Aug 04, 2021
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioSymetrics
BioSymetrics offers a comprehensive portfolio of products and services, including AI Discovery Platform.
Uses machine learning to predict and validate targets for precision medicines
People of BioSymetrics
Unlock access to complete
Unlock access to complete
Funding Insights of BioSymetrics
BioSymetrics has successfully raised a total of $4.88M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.88 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by BioSymetrics
Investment portfolio details for BioSymetrics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioSymetrics
Detailed financials for BioSymetrics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biosymetrics Comparisons
Peer comparison for BioSymetrics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioSymetrics
BioSymetrics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Causaly, Atomwise, ScienceIO, MicroHealth and Collaborative Drug Discovery, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based data-mining tools for scientific evidence discovery are provided.
|
|
| Locked | Locked | Locked |
AI-driven platform for structure-based drug discovery is provided.
|
|
| Locked | Locked | Locked |
Provider of AI solutions transforming medical text into enriched healthcare data
|
|
| Locked | Locked | Locked |
Population health management and care coordination solutions are provided.
|
|
| Locked | Locked | Locked |
Biological and chemical data are managed securely in a database.
|
|
| Locked | Locked | Locked |
Drug development solutions are delivered via cognitive computing platform.
|
Detailed competitors of BioSymetrics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biosymetrics
Complete news archive for BioSymetrics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioSymetrics
BioSymetrics was founded in 2015 and raised its 1st funding round 6 years after it was founded.
BioSymetrics is headquartered in New York, United States. It is registered at New York, New York, United States.
BioSymetrics is a funded company, having raised a total of $4.88M across 1 funding round to date.
BioSymetrics was founded in 2015 and is based in New York, United States. Operations focus on the biomedical sector, where a platform for cognitive computing is provided. Services include data pre-processing, analytics, and zero-latency machine learning applied to bioinformatics, RD clinical informatics, target discovery, and computational biology. Predictive analytics are also delivered for various RD and healthcare datasets.
BioSymetrics offers AI Discovery Platform.